Détail de l'auteur
Documents disponibles écrits par cet auteur (8)
Ajouter le résultat dans votre panier
Visionner les documents numériques
Faire une suggestion Affiner la recherche
Document de travail
J. MESTRE-FERRANDIZ ; P. DEVERKA ; M. PISTOLLATO ; et al. ; Office of Health Economics. (O.H.E.). Londres. GBR | 2014The project reported in this Occasional Paper was intended to determine how changing demands for evidence are affecting drug development in five global pharmaceutical companies: Amgen, Eli Lilly, GSK, Novartis and Sanofi-Aventis. A literature re[...]
Document de travail
P.M. DANZON ; A.K. TOWSE ; J. MESTRE-FERRANDIZ ; National Bureau of Economic Research. (N.B.E.R.). Cambridge CA. USA | Cambridge : N.B.E.R. | 2012This paper analyzes pharmaceutical pricing between and within countries to achieve second best static and dynamic efficiency. We distinguish countries with and without universal insurance, because insurance undermines patients? price sensitivity[...]
Ouvrage
J. MESTRE-FERRANDIZ ; A. MORDOH ; J. SUSSEX ; Office of Health Economics. (O.H.E.). Londres. GBR ; Association of the British Pharmaceutical Industry. (A.B.P.I.). Londres. GBR | Londres : A.B.P.I. | 2012This report provides a clear explanation of the nature of innovation in medicines. A fully revised and expanded version of the 2005 edition, it updates the literature review of the economics of innovation, traces important innovation that has oc[...]
Ouvrage
C. LE PEN ; J.M. GRAF VON SCHULENBURG ; M. GARAU ; A. TOWSE ; L. GARATTINI ; J. COSTA-FONT ; P. DANZON ; M. GARAU, Editeur commercial ; J. MESTRE-FERRANDIZ, Editeur commercial ; Office of Health Economics. (O.H.E.). Londres. GBR, Editeur commercial | Londres : Radcliffe Publishing | 2006Based on a seminar held in November 2005, this book discusses recent developments in pricing and reimbursement within five major European Pharmaceutical markets. Each chapter gives an overview of the current market, including aims, effectiveness[...]
Chapitre
C. LE PEN ; M. GARAU, Editeur commercial ; J. MESTRE-FERRANDIZ, Editeur commercial ; Office of Health Economics. (O.H.E.). Londres. GBR, Editeur commercial | Londres : Radcliffe Publishing | 2006Based on a seminar held in November 2005, this book discusses recent developments in pricing and reimbursement within five major European Pharmaceutical markets. This chapter gives an overview of the current market, including aims, effectiveness[...]
Congrès
J. MESTRE-FERRANDIZ, Editeur commercial ; Jon SUSSEX, Editeur commercial ; Office of Health Economics. (O.H.E.). Londres. GBR, Editeur commercial | Londres : O.H.E. | 2003Ce document rassemble les cinq communications présentées lors du séminaire de l'OHE du 15 décembre 2000 sur le thème des institutions et de la compétitivité industrielle dans l'industrie pharmaceutique internationale. L'objectif était d'analyser[...]
Bulletin : Fascicule
OHE BRIEFING, 52 - 01/10/2009 - Access Mechanisms for Orphan Drugs: A Comparative Study of Selected European Countries
This study compares the pricing and reimbursement (P&R) arrangements implemented in selected EU countries to make coverage decisions on orphan medicinal products (OMPs) and investigates whether these measures have had an impact on their availabi[...]
Bulletin : Fascicule
OHE BRIEFING, 45 - 01/10/2008 - The Market for Biosimilars: Evolution and Policy Options.
Biopharmaceuticals are more complex agents than conventional chemical entities and therefore are more difficult to replicate on patent expiry. Off-patent versions of the originator product cannot rely on a simple demonstration of chemical compar[...]
